secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALATIN TECHNOLOGIES INC (PTN)
CIK:        0000911216
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001654954-23-010188
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palatin partners with UpScriptHealth to expand Vyleesi access via telehealth platform
--------------------------------------------------------------------------------

- Palatin (PTN) entered strategic partnership with telemedicine company UpScriptHealth.
- Vyleesi, the first FDA-approved as-needed HSDD treatment, will be on UpScriptHealth's Women's Telehealth Platform.
- UpScriptHealth's patient base is hundreds of thousands of women; partnership aims to boost HSDD awareness.
- Palatin CEO Carl Spana said the deal fortifies existing telehealth programs and expands patient access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/911216/000165495423010188/0001654954-23-010188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/911216/000165495423010188/ptn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-010188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer